Dyslipidemia increases the risk of cardiovascular events among individuals with renal
disease, and there is a growing body of evidence that it hastens the progression of renal …

Visceral obesity and metabolic abnormalities typical for metabolic syndrome (MS) are the
new epidemic in adolescence. MS is not only the risk factor for cardiovascular disease but …

Dyslipidemia after kidney transplantation is a common complication that has historically
been underappreciated, especially in pediatric recipients. It is also a major modifiable risk …

Background Dyslipidemia is a modifiable risk factor for cardiovascular disease. The
prevalence of dyslipidemia in pKTR (pediatric kidney transplant recipients) under modern …

Background Information on lipid abnormalities in end-stage renal disease (ESRD) mainly
originates from adult patients and small paediatric studies. We describe the prevalence of …

Kidney transplantation in pediatric patients can lead to partial improvement of some of the
cardiometabolic parameters that increase the risk for cardiovascular disease (CVD) in …

Hyperlipidemia is common after renal transplantation (Tx) and contributes to the increased
cardiovascular morbidity seen in the post‐transplant period. Limited data are available on …

Cardiovascular disease is one of the main causes of morbidity and mortality in recipients of
renal transplants. Although the risk for cardiovascular disease is in part genetically …

Despite correction of underlying solid organ failure by transplantation, pediatric transplant
recipients still have increased mortality rates compared to the general pediatric population …

Dyslipidaemia exists frequently after renal transplantation (RTx) and promotes
atherosclerosis. In this study, we examined the association between daily intake of nutrients …